Respiratory Research Unit, Department of Respiratory Medicine and Infectious Diseases, Bispebjerg Hospital, Copenhagen, Denmark.
Shared first authorship.
Eur Respir J. 2023 Sep 9;62(3). doi: 10.1183/13993003.02474-2022. Print 2023 Sep.
There is limited evidence on the pathways leading to severe asthma and we are presently unable to effectively predict the progression of the disease. We aimed to describe the longitudinal trajectories leading to severe asthma and to describe clinical events preceding disease progression in a nationwide population of patients with severe asthma.
We conducted an observational study based on Swedish data from the NORdic Dataset for aSThmA Research (NORDSTAR) research collaboration platform. We identified adult patients with severe asthma in 2018 according to the European Respiratory Society/American Thoracic Society definition and used latent class analysis to identify trajectories of asthma severity over a 10-year retrospective period from 2018.
Among 169 128 asthma patients, we identified 4543 severe asthma patients. We identified four trajectories of severe asthma that were labelled as: trajectory 1 "consistently severe asthma" (n=389 (8.6%)), trajectory 2 "gradual onset severe asthma" (n=942 (20.7%)), trajectory 3 "intermittent severe asthma" (n=1685 (37.1%)) and trajectory 4 "sudden onset severe asthma" (n=1527 (33.6%)). "Consistently severe asthma" had a higher daily inhaled corticosteroid dose and more prevalent osteoporosis compared with the other trajectories. Patients with "gradual onset severe asthma" and "sudden onset severe asthma" developed type 2-related comorbidities concomitantly with development of severe asthma. In the latter group, this primarily occurred within 1-3 years preceding onset of severe asthma.
Four distinct trajectories of severe asthma were identified illustrating different patterns of progression of asthma severity. This may eventually enable the development of better preventive management strategies in severe asthma.
目前对于导致严重哮喘的途径的证据有限,我们目前无法有效地预测疾病的进展。我们旨在描述导致严重哮喘的纵向轨迹,并描述严重哮喘患者全国人群中疾病进展前的临床事件。
我们进行了一项基于瑞典数据的观察性研究,来自北欧哮喘研究协作平台(NORDSTAR)。我们根据欧洲呼吸学会/美国胸科学会的定义,在 2018 年确定了成年严重哮喘患者,并使用潜在类别分析,从 2018 年开始,对 10 年的回顾性期间的哮喘严重程度轨迹进行识别。
在 169128 例哮喘患者中,我们确定了 4543 例严重哮喘患者。我们确定了 4 种严重哮喘轨迹,分别标记为:轨迹 1“持续严重哮喘”(n=389(8.6%)),轨迹 2“逐渐发作严重哮喘”(n=942(20.7%)),轨迹 3“间歇性严重哮喘”(n=1685(37.1%))和轨迹 4“突然发作严重哮喘”(n=1527(33.6%))。“持续严重哮喘”的每日吸入皮质激素剂量较高,且骨质疏松症的患病率高于其他轨迹。“逐渐发作严重哮喘”和“突然发作严重哮喘”的患者在发生严重哮喘的同时出现 2 型相关合并症。在后一组中,这主要发生在严重哮喘发作前 1-3 年内。
确定了 4 种不同的严重哮喘轨迹,说明哮喘严重程度的进展模式不同。这最终可能使严重哮喘的预防管理策略得到更好的发展。